| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/14/2006 | EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 06/14/2006 | DE102004059362A1 Use of oligomeric carbohydrate-lignin-complex containing aqueous hardwood extract (e.g. beech wood extract) as additives with cholesterol binding effect for pharmaceutical preparations, food and feed |
| 06/14/2006 | DE102004058449A1 Tetrahydropyranderivate Tetrahydropyran |
| 06/14/2006 | CN1788019A Neutralizing antibodies against GDF-8 and uses therefor |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1787826A Supplement food for low blood glucose recovery |
| 06/14/2006 | CN1787825A External patch containing estrogen and/or progestogen |
| 06/14/2006 | CN1787823A 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/14/2006 | CN1787819A Method of treating atherosclerosis, dyslipidemias and related conditions and medical composition |
| 06/14/2006 | CN1787815A Use of phthalide derivatives for the treatment and prevention of diabetes mellitus |
| 06/14/2006 | CN1787808A Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles |
| 06/14/2006 | CN1787807A Method of preparing a formulation containing a microdosed active component |
| 06/14/2006 | CN1786138A Appetite stinulating wild grape wine |
| 06/14/2006 | CN1786031A Glucagon kind polypeptide-1 analogue, its preparation method and application |
| 06/14/2006 | CN1785427A Compound calcium preparation for astronaut |
| 06/14/2006 | CN1785387A Capsnle for treating type II diabetes |
| 06/14/2006 | CN1785353A Chinese berbal medicine oral liquid for treating diabetes and its preparation method |
| 06/14/2006 | CN1785348A Compound Chinese medicinal preparation for treating type II diabetes and lowering blood sugar and its preparation method |
| 06/14/2006 | CN1785342A Chinese medicinal composition for treating diabetes, its preparation method and use |
| 06/14/2006 | CN1785326A Chinese herbal medicine extract for body weight reducing and fat reducing and its preparation method |
| 06/14/2006 | CN1785314A Zushi daphneol extract, its preparation method and use |
| 06/14/2006 | CN1785305A Flowery knotwood root fast dispersion solid medicine and its preparation method |
| 06/14/2006 | CN1785293A Quality control method of heart pulse free flow oral preparation |
| 06/14/2006 | CN1785286A Hawthorm extract fat lowering dispersion tablet and its preparation technology |
| 06/14/2006 | CN1785285A Extraction method of hawthorn lenf |
| 06/14/2006 | CN1785284A Medicinal composition containing flowery knotwood root |
| 06/14/2006 | CN1785279A Blood supplementing iron supplementing medicineal preparation and its preparation method |
| 06/14/2006 | CN1785253A Micro-balls of compounding red-rooted salvia injection, and its prepn. method |
| 06/14/2006 | CN1785216A Medicinal composition contg. total ginkgo flavone, its prepn. method and use |
| 06/14/2006 | CN1785205A Dextran iron dispersing agent and its prepn. method |
| 06/14/2006 | CN1785196A Compounding prepn. for treating and preventing cardiovascular or cerebrovascular diseases |
| 06/14/2006 | CN1785189A Method for quality control of compounding metformin glipidide |
| 06/14/2006 | CN1785188A Compounding metformin glipidide prepn. for treating diabetes type II, and its prepn. method |
| 06/14/2006 | CN1785181A Gynostemma pentaphylla tolal glucoside dripping pills and its prepn. method |
| 06/14/2006 | CN1785179A Compounding chewable vitamin tablets and its prepn. method |
| 06/14/2006 | CN1784992A Method for producing sour soymilk contg. microo Yinlanzha konjak sugar for reducing-weight and lowering blood-fat |
| 06/14/2006 | CN1784991A Method for preparing sour soymilk contg. micron Yinlanzha konjak sugar for reducing-weight and lowering blood-fat |
| 06/14/2006 | CN1784983A Method for producing wheat flour with functions of lowering blood-sugar and blood-fat |
| 06/14/2006 | CN1259337C Synthesis, expression, preparation and application for human parathyroid hormone gene mutant |
| 06/14/2006 | CN1259332C C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |
| 06/14/2006 | CN1259325C Diphosphate, preparation and uses of its pharmaceutical preparations |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/14/2006 | CN1259068C Dogwood extraction and its preparation method and usage |
| 06/14/2006 | CN1259046C Soyisoflavone soft capsule and its preparation technology |
| 06/14/2006 | CN1259042C Calcium phenol sulfonate dispersive tablets and their preparation |
| 06/13/2006 | USRE39132 Thiazoline acid derivatives |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060721 Phosphodiesterase inhibitor; antidiabetic agents; atherosclerosis; cardiovascular disorders; polyctstic ovary syndrome; hypotensive agents; hyperglycemic agents |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060679 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 06/13/2006 | US7060675 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 06/13/2006 | US7060504 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |
| 06/13/2006 | US7060305 extracts contain higher concentration of isoflavones; used to treat erectile dysfunction or malfunction |
| 06/13/2006 | CA2282575C Process for preparing a nutritional supplement |
| 06/08/2006 | WO2006060535A2 Indole derivatives for use as ppar active compounds |
| 06/08/2006 | WO2006060461A1 Substituted piperazines as cb1 antagonists |
| 06/08/2006 | WO2006059939A1 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006059768A1 9,10-secopregnane derivative and medicine |
| 06/08/2006 | WO2006059744A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 06/08/2006 | WO2006059730A1 Composition for body fat reduction |
| 06/08/2006 | WO2006059714A1 Composition for prevention and/or treatment of bone diseases, physiologically functional or health foods containing the composition, and medicinal preparations containing the composition as the active ingredient |
| 06/08/2006 | WO2006059507A1 11β-HSD1 ANTISENSE COMPOUND |
| 06/08/2006 | WO2006059224A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same |
| 06/08/2006 | WO2006059210A2 Fused bicyclic pyrrols as hmg-coa reductase inhibitors |
| 06/08/2006 | WO2006059164A2 Pyrrolopyridine-2-carboxylic acid amides |
| 06/08/2006 | WO2006059163A1 Treatment of diabetes with glycogen phosphorylase inhibitors |
| 06/08/2006 | WO2006058923A1 Heteroaromatic glucokinase activators |
| 06/08/2006 | WO2006058920A1 Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of hiv-infected patients |
| 06/08/2006 | WO2006058628A2 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
| 06/08/2006 | WO2006058597A1 Tetrahydropyrane derivatives for use as antidiabetics |
| 06/08/2006 | WO2006044174A3 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
| 06/08/2006 | WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 06/08/2006 | WO2006020676A3 Antisense modulation of apolipoprotein b expression |
| 06/08/2006 | WO2006013427A3 Treatment of ccr2 mediated diseases or disorders |
| 06/08/2006 | WO2006010503A3 Rxr antagonists in the treatment of inflammatory diseases |
| 06/08/2006 | WO2005099671A3 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 06/08/2006 | WO2005062824A8 Anti-hypercholesterolemic compounds |
| 06/08/2006 | US20060122432 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol |
| 06/08/2006 | US20060122411 Chloride channel opener |
| 06/08/2006 | US20060122403 Atorvastatin calcium form vi or hydrates thereof |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122370 Specific binding agents of human angiopoietin-2 |
| 06/08/2006 | US20060122280 Muscarinic agonists |
| 06/08/2006 | US20060122270 Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122244 Hypoglycemic agents; antidiabetic agentys; side effect reduction; cardiovascular disorders; anticancer agents |
| 06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 06/08/2006 | US20060122240 Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122215 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesity |